Priority Date: 24.01.12 (AU 20120900259)

PEPTIDE AGENTS FOR CANCER THERAPY

  • Application ID: EP13740583
  • Status: No opposition filed within time limit

Attorneys

no operation time available
6 offices
active in Legal Services
no operation time available
6 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Symbiosis IP Limited is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 229 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 24.01.2012 - Priority Date (AU 20120900259)
  • 01.08.2013 - Publication A1 (WO2013110120)
  • 03.12.2014 - Publication A1 (EP2807180)
  • 28.03.2018 - Publication B1 (EP2807180)